AFG2B
ATPase family gene 2 protein homolog B
Also known as: AFG2B_HUMAN, FLJ12286, MGC5347, SPATA5L1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BVQ7
- Gene
- AFG2B
- Ensembl
- ENSG00000171763
- Chromosome
- 15
- Canonical length
- 753 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
Enables identical protein binding activity and preribosome binding activity. Involved in ribosomal large subunit biogenesis. Located in cytoplasm and spindle. Implicated in autosomal recessive nonsyndromic deafness. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
753 residues, UniProt reviewed canonical sequence.
>Q9BVQ7|AFG2B
1 MAPDSDPFPE GPLLKLLPLD ARDRGTQRCR LGPAALHALG ARLGSAVKIS LPDGGSCLCT
61 AWPRRDGADG FVQLDPLCAS PGAAVGASRS RRSLSLNRLL LVPCPPLRRV AVWPVLRERA
121 GAPGARNTAA VLEAAQELLR NRPISLGHVV VAPPGAPGLV AALHIVGGTP SPDPAGLVTP
181 RTRVSLGGEP PSEAQPQPEV PLGGLSEAAD SLRELLRLPL RYPRALTALG LAVPRGVLLA
241 GPPGVGKTQL VRAVAREAGA ELLAVSAPAL QGSRPGETEE NVRRVFQRAR ELASRGPSLL
301 FLDEMDALCP QRGSRAPESR VVAQVLTLLD GASGDREVVV VGATNRPDAL DPALRRPGRF
361 DREVVIGTPT LKQRKEILQV ITSKMPISSH VDLGLLAEMT VGYVGADLTA LCREAAMHAL
421 LHSEKNQDNP VIDEIDFLEA FKNIQPSSFR SVIGLMDIKP VDWEEIGGLE DVKLKLKQSI
481 EWPLKFPWEF VRMGLTQPKG VLLYGPPGCA KTTLVRALAT SCHCSFVSVS GADLFSPFVG
541 DSEKVLSQIF RQARASTPAI LFLDEIDSIL GARSASKTGC DVQERVLSVL LNELDGVGLK
601 TIERRGSKSS QQEFQEVFNR SVMIIAATNR PDVLDTALLR PGRLDKIIYI PPPDHKGRLS
661 ILKVCTKTMP IGPDVSLENL AAETCFFSGA DLRNLCTEAA LLALQENGLD ATTVKQEHFL
721 KSLKTVKPSL SCKDLALYEN LFKKEGFSNV EGILocalizationUniProt · AlphaFold · HPA
Whether an antibody against AFG2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 9.7 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 9.7 nTPM
- skeletal muscle: 8.6 nTPM
- liver: 7.1 nTPM
- skin: 7 nTPM
- cerebellum: 6.3 nTPM
- bone marrow: 6 nTPM
Single-cell type
- esophageal apical cells: 86 nCPM
- neutrophils: 65 nCPM
- early spermatids: 49 nCPM
- monocytes: 33 nCPM
- late primary spermatocytes: 29 nCPM
- cone photoreceptor cells: 27 nCPM
Immune cell
- non-classical monocyte: 1.9 nTPM
- memory CD8 T-cell: 1.5 nTPM
- eosinophil: 1.2 nTPM
- gdT-cell: 1.1 nTPM
- neutrophil: 1.1 nTPM
- NK-cell: 1.1 nTPM
Brain region
- white matter: 4.6 nTPM
- cerebellum: 4.5 nTPM
- thalamus: 4 nTPM
- basal ganglia: 3.6 nTPM
- spinal cord: 3.6 nTPM
- cerebral cortex: 3.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AFG2B.
Disease | AllUniProt
Conditions AFG2B is implicated in, by any mechanism.
- Deafness, autosomal recessive, 119 (DFNB119) MIM:619615
- Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) MIM:619616
Disease | GeneticClinVar
21 pathogenic / likely-pathogenic of 175 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with hearing loss and spasticity
- SPATA5L1-associated disorder
- See cases
- Hearing loss, autosomal recessive 119
- AFG2B-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- DepMap mean gene effect
- -1.06
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagosome maturation
- mitotic spindle disassembly
- proteasome-mediated ubiquitin-dependent protein catabolic process
- retrograde protein transport, ER to cytosol
- ribosomal large subunit biogenesis
Molecular functions
- ATP binding
- ATP hydrolysis activity
- identical protein binding
- polyubiquitin modification-dependent protein binding
- preribosome binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AFG2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AFG2B as an antibody target. Whether an autoantibody or antibody against AFG2B could matter depends on whether native AFG2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AFG2B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AFG2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...